Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Serendipity Capital is a private Singapore-based venture capital and permanent capital investment firm focused on disruptive technology themes rather than drug development. The firm invests in companies working in artificial intelligence and machine learning, climate and sustainability, quantum technologies, and security, with a stated emphasis on technologies that enhance and secure critical infrastructure. Its website and company profiles position it as a long-term investment partner that provides capital, strategic introductions, and hands-on support to a concentrated portfolio. Although the firm mentions healthcare as one of the sectors where its portfolio technologies may have use cases, it does not appear to be a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Serendipity Capital.